In addition, van Wely et al., by assessing the external validity of the model predicting the individual FSH response dose, found that it was inadequate in CC-resistant PCOS patients undergoing ovulation induction with recombinant FSH (rFSH) in a low-dose step-up regimen [75]. The gene discussed is BRD2; the disease is polycystic ovary syndrome.